Institute of Musculoskeletal Health and Arthritis (IMHA)
The purpose of this Request for Applications is to enable developing or established researchers to spend up to three months in a specific location focusing on the acquisition of new concepts, knowledge, or techniques to broaden their research perspectives and skills. It is expected that this targeted investment will lead to multidisciplinary networks both within and outside of Canada.
IMHA's first priority is to support innovative health research that maps to one or more of its strategic research priorities across one or more of CIHR's four health research pillars. The Institute's strategic research priorities are:
| May 1 | For short-term visits slated between September and February, the deadline for Full Application is May 1. |
| November 1 | For short-term visits slated between March and August, the deadline for Full Application is November 1. |
| June 1 and December 1 | Notification of decision. |
| Proposed Start Date of Short Term Visit must be within twelve (12) month period from application submission date. | |
| Duration |
Up to 3 months. |
| Funding |
For this Initiative: Per Grant: |
Background
Partners
Objectives and Eligible Research Areas
Funding Information
Eligibility
Evaluation Criteria and Process
General IMHA Guidelines and Conditions of Funding
Communication Requirements
Monitoring, Performance Measurement and Evaluation
How to Apply
Contact Information
Description fo Partner: Osteoporosis Canada (OC)
The Institute of Musculoskeletal Health and Arthritis (IMHA) is dedicated to bringing a broad range of stakeholders together to shape a national research agenda and help CIHR further its goal - not only to create new knowledge, but also to translate and exchange that knowledge such that the health and health care of all Canadians will be improved.
Representing six equally important focus areas - arthritis, MSK rehabilitation, bone, skeletal muscle, skin and oral health, IMHA is committed to "sustaining health and enhancing quality of life by eradicating the pain, suffering and disability caused by arthritis, musculoskeletal, oral and skin conditions."
IMHA is dedicated to identifying and developing collaborations with other CIHR institute(s), funding organizations and stakeholders to enhance the availability of funding for this strategic initiative, and to create, where appropriate, opportunities for knowledge exchange and translation related to the scope of this particular initiative.
This initiative, provided to Osteoporosis Canada by the Alliance for Better Bone Health - P&G Pharmaceuticals and Sanofi Aventis - will provide matching funding for one award per fiscal year to junior researchers (graduate students, postdoctoral fellows or junior investigators), including MDs and practicing clinicians, in the area of Metabolic Bone Disease. This partnered funding will be named the 'Dr. Timothy Murray Excellence in Osteoporosis Alliance Award'.
The objective of the Short-Term Visits Module is:
Eligible research areas include:
Mechanism of Support
This Request for Applications will follow the General Guidelines for All Research Grants.
Allowable Costs
Applicants should review Use of Grant Funds and Eligibility of Expenses, Employment under Grants within the General Guidelines for All Research Grants for a complete listing and description of allowable costs and activities.
For the Research Allowance, applicants should review General Guidelines for All Research Grants for a complete listing and description of allowable costs and activities.
The full application must provide a detailed justification of all costs.
Eligibility Criteria
Eligibility criteria for all CIHR research funding programs apply. The business office of the institution of an eligible Applicant generally administers IMHA funds. Please refer to the Eligibility Requirements for CIHR Grants and Awards regarding the eligibility requirements for individuals and institutions.
Specific Eligibility Requirements
Eligibility requirements specific to this Request for Applications include the following:
Evaluation Criteria
Each proposal must describe how the grant will address one of the important health issues described under "Objectives and Eligible Research Areas." General criteria for assessing applications are listed below. Because different applications will emphasize different approaches to research and to knowledge translation/exchange, it is understood that the Review Committee will weigh questions such as these differently from one application to another.
The research proposed to be undertaken during the Short-Term Visit:
The Applicant's productivity, experience and training:
In addition to these general criteria, the Review Committee will consider the criteria below:
Evaluation Process
All personal information collected by IMHA about applicants is used to review applications, to administer and monitor grants and awards, to compile statistics, and to promote and support health research in Canada. Consistent with these purposes, applicants should also expect that information collected by IMHA may be shared as described in Use and Disclosure of Personal Information Provided to CIHR for Peer Review.
The relevance review will be based on the extent to which the proposed research relates to the mandate and strategic research priorities of the Institute and for the Dr. Timothy Murray Award, the extent to which the proposed research relates to Metabolic Bone Disease.
A subcommittee of the Institute Advisory Board will evaluate all applications. Review of applications to the OC and IMHA partnered award will also involve two reviewers nominated by the OC. On completion of the review, IMHA will receive the ranking lists, merit scores (ratings) and recommendation of the subcommittee for the applications submitted. Based on the total funds available for the initiative, applications will be funded from the top-ranked top ranked down as far as budgets will allow. Applications receiving a score of less than 3.5 will not be considered for funding. CIHR's policy on Conflict of Interest, Confidentiality and Privacy Issues in Peer Review will be adhered to.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
CIHR as a federal entity is subject to the Access to Information Act and the Privacy Act, therefore the requirements of these two statutes will apply to all information located in IMHA's premises.
The Parties, while respecting the application of the Privacy Act to federal entities, will also be bound by the PIPEDA. All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under cost-sharing agreements related to the Request for Applications will be collected, used and disclosed in compliance with the PIPEDA.
All conditions specified in CIHR General Grants and Awards Policies shall apply to applications funded through this Request for Applications. Conditions cover areas such as Applicant and Institutional Responsibilities, Ethics, Official language policy, Access to Information and Privacy Acts, and Acknowledgement of IMHA Support.
In addition to IMHA standard guidelines and requirements, the following special conditions shall apply:
Grant recipients are required to acknowledge CIHR and IMHA in any communication or publication related to the project. See CIHR General Grants and Awards Policies, Acknowledgement of CIHR's Support for details on CIHR's communication requirements.
CIHR and IMHA are committed to demonstrating results to Canadians for the money invested in health research. Therefore, processes for monitoring progress and appropriate use of funds, as well as for performance measurement and program evaluation are in place. As a result, funding recipients must:
Send One Application, by Courier, to:
RE: "Mentorship Program: Short-Term Visit Module"
c/o E. Robson
Institute of Musculoskeletal Health and Arthritis
Room 451A, HMRB, 3330 Hospital Drive NW
Calgary, Alberta T2N 1N4
Send one application, electronically, to:
SUBJ: "Mentorship Program: Short-Term Visit Module"
robson@ucalgary.ca
Full Application
The Applicant is required to submit the following documentation for Full Application:
For questions about this initiative and research objectives, IMHA's funding guidelines, application instructions, or the review process, contact:
Elizabeth Robson
Administrative Officer / Stakeholder Relations
Institute of Musculoskeletal Health and Arthritis
Rm 451A, HMRB, 3330 Hospital Drive NW
Calgary, Alberta T2N 4N1
Telephone: (403) 320-0068
Fax: (403) 210-8149
Email: robson@ucalgary.ca
The goal of the Osteoporosis Canada is to educate, empower and support individuals and communities in the prevention and treatment of osteoporosis.
OC Vision: A nation without osteoporotic fractures.
OC Mission: To work towards a future where all Canadians will:
